Specifically, PD-L1 expression was shown to be upregulated after neoadjuvant chemotherapy in urothelial carcinoma [38] and in NSCLC [39,40] as well as in adjuvant settings in NSCLC [41] (Figure 1F). The gene discussed is CD274; the disease is urothelial carcinoma.